Emcure Pharmaceuticals has announced the dispatch of a letter to its members, providing a web-link and QR code for the Annual Report 2025-26 and the Notice for the 45th Annual General Meeting (AGM). The AGM is scheduled for Monday, September 21, 2026, and will be conducted via video conferencing. This communication is particularly for members who have not registered their email addresses.
Shareholder Communication for AGM
Emcure Pharmaceuticals Limited is informing its shareholders about the dispatch of important documents related to the upcoming 45th Annual General Meeting (AGM). In compliance with regulatory requirements, the company has sent a letter to members who have not yet registered their email addresses with the company or its depositories. This letter provides a direct web-link and QR code for accessing the complete Annual Report for the financial year 2025-26 and the official Notice of the 45th AGM.
AGM Details and Access to Reports
The 45th AGM of Emcure Pharmaceuticals Limited is scheduled to be held on Monday, September 21, 2026. To facilitate attendance and access to information, the meeting will be conducted through Video Conferencing (VC) facility / Other Audio Visual Means (OAVM). Members can access the Annual Report and the AGM Notice via the following links provided by the company:
- Notice of 45th AGM: https://www.emcure.com/wp-content/uploads/2026/08/Notice-of-45th-AGM-21st-Sept-2026.pdf
- Annual Report FY 2025-26: https://www.emcure.com/wp-content/uploads/2026/08/Annual-Report-FY-2025-26.pdf
This communication is a key step to ensure all shareholders receive timely information and can participate in the company’s governance processes. Members are encouraged to update their records and utilize the provided digital resources.
Source: BSE
